RCSA
NVAX icon

REYL & Cie S.A.’s Novavax NVAX Stock Holding History

REYL & Cie S.A.’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$816 Buy
+100
New +$896 ﹤0.01% 153

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

REYL & Cie S.A.'s NVAX Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in Novavax (NVAX) in Q2 2026: 100 shares worth $816. The stake represents ﹤0.01% of the portfolio and ranks #153 among its holdings.

268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • REYL & Cie S.A. held 100 shares of Novavax worth $816 as of Q2 2026.
  • Novavax was a new REYL & Cie S.A. position in Q2 2026.
  • Novavax made up ﹤0.01% of REYL & Cie S.A.'s portfolio in Q2 2026, its #153 holding.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.